Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0CX7N
|
||||
| Former ID |
DNC008822
|
||||
| Drug Name |
8-Bromo-9-(3-hydroxypropyl)-9H-adenine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530014] | ||
| Formula |
C8H10BrN5O
|
||||
| Canonical SMILES |
C1=NC2=C(C(=N1)N)N=C(N2CCCO)Br
|
||||
| InChI |
1S/C8H10BrN5O/c9-8-13-5-6(10)11-4-12-7(5)14(8)2-1-3-15/h4,15H,1-3H2,(H2,10,11,12)
|
||||
| InChIKey |
MUZYIFHIQGFDMZ-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Adenosine A2a receptor | Target Info | Inhibitor | [530014] | |
| Adenosine A2b receptor | Target Info | Inhibitor | [530014] | ||
| Adenosine A1 receptor | Target Info | Inhibitor | [530014] | ||
| Adenosine A3 receptor | Target Info | Inhibitor | [530014] | ||
| KEGG Pathway | Rap1 signaling pathway | ||||
| Calcium signaling pathway | |||||
| cAMP signaling pathway | |||||
| Neuroactive ligand-receptor interaction | |||||
| Vascular smooth muscle contraction | |||||
| Parkinson's disease | |||||
| Alcoholismhsa04015:Rap1 signaling pathway | |||||
| Alcoholismhsa04022:cGMP-PKG signaling pathway | |||||
| Sphingolipid signaling pathway | |||||
| Morphine addiction | |||||
| Pathway Interaction Database | HIF-2-alpha transcription factor networkcmyb_pathway:C-MYB transcription factor network | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.